These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17881430)

  • 1. International Conference on Memory (ICOM-4), University of New South Wales, Sydney, Australia, 16-21 July 2006 Ecstasy/MDMA and Memory Symposium.
    Parrott AC; McGregor IS; Lee TM; Scholey AB; Morgan MJ
    J Psychopharmacol; 2007 Nov; 21(8):895-7. PubMed ID: 17881430
    [No Abstract]   [Full Text] [Related]  

  • 2. The neuropsychology of ecstasy (MDMA) use: a quantitative review.
    Zakzanis KK; Campbell Z; Jovanovski D
    Hum Psychopharmacol; 2007 Oct; 22(7):427-35. PubMed ID: 17896346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDMA (3,4-methylenedioxymethamphetamine) or ecstasy: the contemporary human and animal research perspective.
    Parrott AC; Marsden CA
    J Psychopharmacol; 2006 Mar; 20(2):143-6. PubMed ID: 16510473
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
    Indlekofer F; Piechatzek M; Daamen M; Glasmacher C; Lieb R; Pfister H; Tucha O; Lange KW; Wittchen HU; Schütz CG
    J Psychopharmacol; 2009 Jul; 23(5):495-509. PubMed ID: 18635709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of Ecstasy on memory is moderated by a functional polymorphism in the cathechol-O-methyltransferase (COMT) gene.
    Schilt T; Koeter MW; de Win MM; Zinkstok JR; van Amelsvoort TA; Schmand B; den Brink Wv
    Eur Neuropsychopharmacol; 2009 Feb; 19(2):116-24. PubMed ID: 19042106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of a novel animal model of intermittent MDMA ("Ecstasy") exposure during adolescence.
    Meyer JS; Piper BJ; Vancollie VE
    Ann N Y Acad Sci; 2008 Oct; 1139():151-63. PubMed ID: 18991859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ecstasy-related deficits in the updating component of executive processes.
    Montgomery C; Fisk JE
    Hum Psychopharmacol; 2008 Aug; 23(6):495-511. PubMed ID: 18512857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds.
    Bedi G; Redman J
    Psychol Med; 2008 Sep; 38(9):1319-30. PubMed ID: 18226286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Have Halpern et al. (2004) detected 'residual neuropsychological effects' of MDMA? Not likely.
    Lyvers M; Hasking P
    Drug Alcohol Depend; 2004 Aug; 75(2):149-52; discussion 153. PubMed ID: 15276219
    [No Abstract]   [Full Text] [Related]  

  • 10. Metamemory in recreational ecstasy polydrug users: what do self-reports of memory failures mean?
    Bedi G; Redman J
    J Psychopharmacol; 2008 Nov; 22(8):872-81. PubMed ID: 18208933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ecstasy (3,4-methylenedioxymethamphetamine)-induced inappropriate antidiuretic hormone secretion.
    Farah R; Farah R
    Pediatr Emerg Care; 2008 Sep; 24(9):615-7. PubMed ID: 18797371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Learning and memory deficits in ecstasy users and their neural correlates during a face-learning task.
    Roberts GM; Nestor L; Garavan H
    Brain Res; 2009 Oct; 1292():71-81. PubMed ID: 19631624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between the negative effects attributed to ecstasy use and measures of cognition and mood among users.
    Fisk JE; Montgomery C; Murphy PN
    Exp Clin Psychopharmacol; 2009 Oct; 17(5):326-36. PubMed ID: 19803632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memory and mood during the night and in the morning after repeated evening doses of MDMA.
    Kuypers KP; Wingen M; Ramaekers JG
    J Psychopharmacol; 2008 Nov; 22(8):895-903. PubMed ID: 18974173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressin and oxytocin as neurohormonal mediators of MDMA (ecstasy) sociosexual behavioural effects.
    Emanuele E; Arra M; Pesenti S
    Med Hypotheses; 2006; 67(5):1250-1. PubMed ID: 16814476
    [No Abstract]   [Full Text] [Related]  

  • 16. No evidence of decrease in cognitive function in users of low-dose Ecstasy.
    Krebs TS; Johansen PØ
    Arch Gen Psychiatry; 2008 Feb; 65(2):236; author reply 236-7. PubMed ID: 18250261
    [No Abstract]   [Full Text] [Related]  

  • 17. Sprague-Dawley rats display metabolism-mediated sex differences in the acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
    Fonsart J; Menet MC; Declèves X; Galons H; Crété D; Debray M; Scherrmann JM; Noble F
    Toxicol Appl Pharmacol; 2008 Jul; 230(1):117-25. PubMed ID: 18358511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A.
    Alves E; Summavielle T; Alves CJ; Custódio JB; Fernandes E; de Lourdes Bastos M; Tavares MA; Carvalho F
    Addict Biol; 2009 Apr; 14(2):185-93. PubMed ID: 19076925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y protects retinal neural cells against cell death induced by ecstasy.
    Alvaro AR; Martins J; Costa AC; Fernandes E; Carvalho F; Ambrósio AF; Cavadas C
    Neuroscience; 2008 Mar; 152(1):97-105. PubMed ID: 18249070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.